Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MAKEMYTRIP LIMITED

(MMYT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Paytm, MakeMyTrip, Infosys offer to help India with COVID vaccine bookings

06/10/2021 | 07:30pm EDT

BENGALURU, June 10 (Reuters) - Paytm, Infosys and MakeMyTrip are among companies seeking approval in India to provide online COVID-19 vaccine bookings, the head of the government's tech platform said, as the country tries to make it easier for its huge population to book shots.

The government relaxed rules last month to potentially allow third-party apps to offer vaccine bookings and has taken back control of procurement from states following delays and shortages. It also faced initial problems with its own vaccine booking platform.

Around 15 state agencies and private companies, which also include Indian healthcare giants Apollo and Max, and online pharmacy 1mg, have asked to be allowed to offer vaccine bookings, R.S. Sharma, head of the government's panel managing the CoWIN vaccination registration platform, told Reuters.

Softbank-backed digital payments app Paytm has more than 100 million monthly active users and MakeMyTrip has 12 million. Their popularity is seen providing more options to Indians looking to book their COVID-19 shots, particularly if they are struggling with an unfamiliar government platform.

"It will work in favour of the country, the union of all the entities is better than just one individual platform," Sharma said.

MakeMyTrip CEO Rajesh Magow said the company wanted to help people book their vaccination slots. 1mg said it was waiting for government approvals. Apollo declined to comment, while Paytm, Infosys and Max did not respond to Reuters queries.

Only 3.5% of India's 1.3 billion population has been fully immunised against COVID-19 and health officials say the pace will have to ramp up to avoid further deadly surges of the virus, like the one that swept the country in the spring.

While much will depend on a pick up in scarce vaccine supplies, experts say more booking options should help. Several software developers have already been using publicly available coding for the CoWIN platform to create tools that send Telegram alerts to help people book slots.

"Right now, even if you find a slot using alerts, you have to still go to the government website and follow many steps. Companies will be able to give a better user experience compared to CoWIN," said Berty Thomas, a software developer who had designed Telegram alerts for notifying people about slots.

Paytm too has enabled a notification feature on its app.

Sharma said vaccine supplies should improve going forward and praised the CoWIN platform, saying at least three African nations - Zambia, Nigeria and Malawi - had enquired about using it for their own vaccination drives.

"We will give them the portal free of cost and they can customize. This is highly scalable," said Sharma. (Reporting by Uday Sampath in Bengaluru and Aditya Kalra in New Delhi Editing by Sanjeev Miglani and Mark Potter)


ę Reuters 2021
Stocks mentioned in the article
ChangeLast1st jan.
APOLLO HOSPITALS ENTERPRISE LIMITED -0.41% 3244.8 Delayed Quote.35.04%
INFOSYS LIMITED -0.58% 1503.15 Delayed Quote.20.39%
MAKEMYTRIP LIMITED 3.10% 31.96 Delayed Quote.4.98%
SOFTBANK GROUP CORP. -0.18% 7688 End-of-day quote.-4.59%
All news about MAKEMYTRIP LIMITED
06/15India to expedite Amazon, Flipkart antitrust probe as tech focus intensifies ..
RE
06/10Paytm, MakeMyTrip, Infosys offer to help India with COVID vaccine bookings
RE
06/10Paytm, MakeMyTrip, Infosys offer to help India with COVID vaccine bookings
RE
06/01MAKEMYTRIPá : Ambit Capital Initiates Coverage on MakeMyTrip With Buy Rating, $3..
MT
05/25SECTOR UPDATE : Consumer Stocks Gain Pre-Bell Tuesday
MT
05/25MAKEMYTRIPá : Swings to Fiscal Q4 Profit, Revenue Declines
MT
05/25MAKEMYTRIPá : Announces Fiscal 2021 Fourth Quarter and Full Year Financial & Ope..
PU
05/25MAKEMYTRIPá : Press Release PDF 176 KB
PU
05/25MAKEMYTRIP : Fiscal Q4 Earnings Snapshot
AQ
05/25MAKEMYTRIPá : ANNOUNCES FISCAL 2021 FOURTH QUARTER AND FULL YEAR RESULTS (Form 6..
PU
More news
Financials (USD)
Sales 2021 173 M - -
Net income 2021 -64,0 M - -
Net cash 2021 197 M - -
P/E ratio 2021 -69,9x
Yield 2021 -
Capitalization 3 201 M 3 201 M -
EV / Sales 2021 17,4x
EV / Sales 2022 8,06x
Nbr of Employees 3 960
Free-Float 44,6%
Chart MAKEMYTRIP LIMITED
Duration : Period :
MakeMyTrip Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MAKEMYTRIP LIMITED
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Last Close Price 31,00 $
Average target price 32,17 $
Spread / Average Target 3,76%
EPS Revisions
Managers and Directors
NameTitle
Rajesh Magow Group Chief Executive Officer & Director
Mohit Kabra Group Chief Financial Officer & Director
Deep Kalra Executive Chairman
Aditya Tim Guleri Independent Director
Jian Zhang Liang Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
MAKEMYTRIP LIMITED4.98%3 201
BOOKING HOLDINGS INC.1.06%92 406
EXPEDIA GROUP, INC.26.08%24 534
TRIP.COM GROUP LIMITED9.28%23 388
TONGCHENG-ELONG HOLDINGS LIMITED32.80%5 644
TRIPADVISOR, INC.40.90%5 552